Persona SoluTion PPS Femur PMCF
← catalyst calendarNCT07286513 · readout ≤ 1,230 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Enrolling by invitation
Study type
Observational
Enrollment
200estimated
Sites
3
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-02-26 | actual | When the study began enrolling |
| Primary completion | Dec 2029 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2037 | estimated | The whole study's end, after follow-up |
| First posted | 2025-12-16 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-17 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Rhematoid Arthritis
- Osteo Arthritis of the Knee
- Traumatic Arthritis of Knee (Diagnosis)
- Polyarthritis
- Collagen Disorders
- Avascular Necrosis of Femoral Condyle
- Valgus Deformity
- Varus Deformity
- Flexion Deformity of Knee
Intervention
- Device: Total knee arthroplasty — also filed as Total Knee replacement
Primary outcome
what the primary-completion date above is the date OFChange in KOOS JR Score between pre-op and 2 years post-op
measured 2 years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed